Abstract Purpose of Review Novel coronavirus disease 2019 (COVID-19) has been
associated with an increased risk of arterial and venous thromboembolic (VTE) diseases …

Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months,
causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation …

Abstract Coronavirus disease‐19 (COVID‐19) started in Wuhan, China in December 2019
and spread to all around the world in a short period of time. Hospitalized patients with …

Background Best practice for prevention, diagnosis, and management of venous
thromboembolism (VTE) in patients with coronavirus disease 2019 (COVID‐19) is unknown …

ABSTRACT COVID-19 pneumonia has been associated with high rates of thrombo-embolic
complications, mostly venous thromboembolism (VTE), which is thought to be a combination …

COVID‐19 (severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]) is associated
with coagulopathy through numerous mechanisms. The reported incidence of venous …

Background: Recent studies revealed a high prevalence of venous thromboembolism (VTE)
events in coronavirus disease 2019 (COVID-19) patients, especially in those who are …

Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …

AIMS OF THE STUDY Many centres have noticed a high number of venous
thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia …

A common and potent consideration has recently entered the landscape of the novel
coronavirus disease of 2019 (COVID-19): venous thromboembolism (VTE). COVID-19 has …